Author

Nitsan Maharshak

Vedolizumab is effective and safe in elderly inflammatory bowel disease patients: a binational, multicenter, retrospective cohort study
Vedolizumab is effective and safe in elderly inflammatory bowel disease patients: a binational, multicenter, retrospective cohort study

Nitsan Maharshak

CROHN'S DISEASE EXCLUSION DIET INDUCES REMISSION IN ADULTS WITH MILD TO MODERATE CROHN´S DISEASE: PRELIMINARY REPORT FROM A RANDOMISED CONTROLLED TRIAL (CDED-AD TRIAL)
CROHN'S DISEASE EXCLUSION DIET INDUCES REMISSION IN ADULTS WITH MILD TO MODERATE CROHN´S DISEASE: PRELIMINARY REPORT FROM A RANDOMISED CONTROLLED TRIAL (CDED-AD TRIAL)

Nitsan Maharshak  et al.

VIDEO CAPSULE ENDOSCOPY MAY DETECT ACTIVE SMALL BOWEL CROHN’S DISEASE REQUIRING CHANGE OF TREATMENT DESPITE UNREMARKABLE ILEO-COLONIC ANASTOMOSIS
VIDEO CAPSULE ENDOSCOPY MAY DETECT ACTIVE SMALL BOWEL CROHN’S DISEASE REQUIRING CHANGE OF TREATMENT DESPITE UNREMARKABLE ILEO-COLONIC ANASTOMOSIS

Nitsan Maharshak  et al.

ANTI-TNF AGENTS AND VEDOLIZUMAB HAVE SIMILAR SAFETY AS FIRST-LINE BIOLOGIC TREATMENT OF ELDERLY PATIENTS WITH ULCERATIVE COLITIS
ANTI-TNF AGENTS AND VEDOLIZUMAB HAVE SIMILAR SAFETY AS FIRST-LINE BIOLOGIC TREATMENT OF ELDERLY PATIENTS WITH ULCERATIVE COLITIS

Nitsan Maharshak  et al.

ECONOMIC AND CHRONOLOGIC OPTIMIZATION OF FECAL DONOR RECRUITMENT IN THE BACTERIOTHERAPY CLINIC. ANALYSIS OF 5 YEARS OF ACTIVITY
ECONOMIC AND CHRONOLOGIC OPTIMIZATION OF FECAL DONOR RECRUITMENT IN THE BACTERIOTHERAPY CLINIC. ANALYSIS OF 5 YEARS OF ACTIVITY

Nitsan Maharshak  et al.

MEDICAL CANNABIS REDUCES PAIN AND IMPROVES SLEEP QUALITY IN CROHN'S DISEASE PATIENTS. A PROSPECTIVE OBSERVATIONAL STUDY
MEDICAL CANNABIS REDUCES PAIN AND IMPROVES SLEEP QUALITY IN CROHN'S DISEASE PATIENTS. A PROSPECTIVE OBSERVATIONAL STUDY

Nitsan Maharshak  et al.

ISOPERISTALTIC ILEOCOLONIC ANASTOMOSIS AFTER ILEOCECAL RESECTION REDUCES COLONOSCOPIC ANASTOMOSIS-TO-SMALL-BOWEL TIME
ISOPERISTALTIC ILEOCOLONIC ANASTOMOSIS AFTER ILEOCECAL RESECTION REDUCES COLONOSCOPIC ANASTOMOSIS-TO-SMALL-BOWEL TIME

Nitsan Maharshak  et al.

EARLY SURGERY AFTER HOSPITALIZATION WITH PENETRATING CROHN’S DISEASE REDUCES ADVERSE SEQUELAE COMPARED TO CONSERVATIVE TREATMENT
EARLY SURGERY AFTER HOSPITALIZATION WITH PENETRATING CROHN’S DISEASE REDUCES ADVERSE SEQUELAE COMPARED TO CONSERVATIVE TREATMENT

Nitsan Maharshak  et al.

CROHN'S DISEASE EXCLUSION DIET (CDED) FOR THE TREATMENT OF CROHN'S DISEASE – AN OBSERVATIONAL STUDY FROM A TERTIARY CENTER
CROHN'S DISEASE EXCLUSION DIET (CDED) FOR THE TREATMENT OF CROHN'S DISEASE – AN OBSERVATIONAL STUDY FROM A TERTIARY CENTER

Nitsan Maharshak  et al.

ABDOMINALLY TARGETED, YOGA-BASED PHYSICAL EXERCISES AS A THERAPEUTIC INTERVENTION FOR INFLAMMATORY BOWEL DISEASE
ABDOMINALLY TARGETED, YOGA-BASED PHYSICAL EXERCISES AS A THERAPEUTIC INTERVENTION FOR INFLAMMATORY BOWEL DISEASE

Nitsan Maharshak  et al.

QINGDAI (QD) FOR PATIENTS WITH ACTIVE ULCERATIVE COLITIS: A RETROSPECTIVE ISRAELI NATIONAL EXPERIENCE
QINGDAI (QD) FOR PATIENTS WITH ACTIVE ULCERATIVE COLITIS: A RETROSPECTIVE ISRAELI NATIONAL EXPERIENCE

Nitsan Maharshak  et al.

CLINICAL EFFICACY OF FECAL MICROBIAL TRANSPLANTATION TREATMENT IN ADULTS WITH MODERATE-TO-SEVERE ATOPIC DERMATITIS
CLINICAL EFFICACY OF FECAL MICROBIAL TRANSPLANTATION TREATMENT IN ADULTS WITH MODERATE-TO-SEVERE ATOPIC DERMATITIS

Nitsan Maharshak  et al.

BROAD HOST RANGE BACTERIOPHAGE THERAPY FOR REDUCTION OF KLEBSIELLA PNEUMONIAE AS A POTENTIAL TREATMENT IN IBD
BROAD HOST RANGE BACTERIOPHAGE THERAPY FOR REDUCTION OF KLEBSIELLA PNEUMONIAE AS A POTENTIAL TREATMENT IN IBD

Nitsan Maharshak  et al.

REAL-LIFE EFFECTIVENESS OF TOFACITINIB IN TWO INDICATIONS IN ULCERATIVE COLITIS: A RETROSPECTIVE WORLDWIDE, MULTICENTER, COLLABORATIVE STUDY
REAL-LIFE EFFECTIVENESS OF TOFACITINIB IN TWO INDICATIONS IN ULCERATIVE COLITIS: A RETROSPECTIVE WORLDWIDE, MULTICENTER, COLLABORATIVE STUDY

Nitsan Maharshak  et al.

USTEKINUMAB IS SUPERIOR IN TREATMENT PERSISTENCE AND COLECTOMY-FREE SURVIVAL AMONG SEQUENTIAL BIOLOGICAL THERAPIES IN MODERATE-TO-SEVERE ULCERATIVE COLITIS REFRACTORY TO ANTI-TNF – PRELIMINARY DATA OF A RETROSPECTIVE, MULTICENTRE STUDY
USTEKINUMAB IS SUPERIOR IN TREATMENT PERSISTENCE AND COLECTOMY-FREE SURVIVAL AMONG SEQUENTIAL BIOLOGICAL THERAPIES IN MODERATE-TO-SEVERE ULCERATIVE COLITIS REFRACTORY TO ANTI-TNF – PRELIMINARY DATA OF A RETROSPECTIVE, MULTICENTRE STUDY

Nitsan Maharshak  et al.

COMPARISON OF FECAL TRANSPLANTATION, FECAL TRANSPLANTATION WITH THE NOVEL UC DIET OR THE UC DIET ALONE FOR REFRACTORY MILD TO MODERATE ACTIVE ULCERATIVE COLITIS: THE CRAFT UC RANDOMIZED CONTROLLED TRIAL
COMPARISON OF FECAL TRANSPLANTATION, FECAL TRANSPLANTATION WITH THE NOVEL UC DIET OR THE UC DIET ALONE FOR REFRACTORY MILD TO MODERATE ACTIVE ULCERATIVE COLITIS: THE CRAFT UC RANDOMIZED CONTROLLED TRIAL

Nitsan Maharshak  et al.

EFFECTIVENESS OF THIRD-CLASS BIOLOGIC TREATMENT IN CROHN´S DISEASE: A MULTI-CENTER RETROSPECTIVE COHORT STUDY
EFFECTIVENESS OF THIRD-CLASS BIOLOGIC TREATMENT IN CROHN´S DISEASE: A MULTI-CENTER RETROSPECTIVE COHORT STUDY

Nitsan Maharshak  et al.

Item 1 - 17 / 17
1